Kinnevik Investment


Babylon goes the SPAC route, Kinnevik to book SEK1.8bn in excess value

03/06/21 -"Following the holding company’s 31 May ad hoc announcement regarding a potential listing of Babylon Health, Kinnevik has just confirmed that the company will go public through a SPAC merger ..."

Pages
65
Language
English
Published on
03/06/21
You may also be interested by these reports :
30/07/26
GBL reported good performance from its private assets during the second quarter, both operationally and financially. We remain skeptical on the ...

30/07/26
LSEG posted solid H1 26 results, in line with consensus and our estimates. Organic growth decelerated in Q2 (+7.1% vs +9.8% in Q1) due to market ...

30/07/26
Wendel delivered decent execution in H1, with WIM confirming its targets, resilient but uneven portfolio performance, and shareholder returns ahead ...

30/07/26
Sonae announced good Q2 26 results, demonstrating the defensiveness of its underlying businesses with good organic growth despite a harder macro ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO